Olympics In China Causes Bulk-Drug Prices To Rise In India
This article was originally published in PharmAsia News
The onset of the Olympics games in China already is having a fallout in India where drug makers are seeing the price of bulk drugs increasing. The Chinese government ordered several chemical firms that make the drugs to cease production temporarily to help reduce air pollution that threatens to plague the sporting events in Beijing. Even though the All India Association of Chemists and Druggists said some prices already have risen in advance of the games, the real impact is yet to be felt. Because of the rise in the price of ranitidine, aminophyline, amoxylitline and ampicillin, some of which have increased by half in the past three months, some Indian drug makers are working hard to find alternate sources. (Click here for more
You may also be interested in...
The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.
Beneficiaries in nursing homes and in rural areas will benefit from a telehealth expansion in the final CMS physician fee schedule rule.
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.